PABPC1L1: Potential Drug Target and Biomarker (G80336)

Target Name: PABPC1L

NCBI ID: G80336

PABPC1L

PABPC1L1: Potential Drug Target and Biomarker

PABPC1L1 (PABPC1L1) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the PABPC1 family, which is known for its role in cell signaling and metabolism. While the exact function of PABPC1L1 is not yet well understood, research has shown that it is involved in a number of important cellular processes, including cell signaling, inflammation, and stress resistance.

Drug Targeting

PABPC1L1 is a potential drug target due to its involvement in various cellular processes that are linked to human disease. One of the primary targets for PABPC1L1 is the regulation of inflammation. Chronic inflammation is associated with a number of diseases, including heart disease, diabetes, and neurodegenerative disorders. PABPC1L1 has been shown to play a role in the regulation of inflammation by promoting the production of pro-inflammatory cytokines and inhibiting the production of anti-inflammatory cytokines.

In addition to its role in inflammation, PABPC1L1 is also involved in the regulation of cell signaling. It has been shown to play a role in the regulation of cell proliferation, differentiation, and survival. PABPC1L1 has been shown to promote the growth and survival of cancer cells, and it has also been shown to inhibit the growth and survival of healthy cell lines.

PABPC1L1 is also involved in the regulation of stress resistance, which is important for maintaining cellular homeostasis in the face of environmental stressors, such as UV radiation, radiation, and chemical stressors.

Biomarker

PABPC1L1 has also been shown to be a potential biomarker for a number of diseases, including neurodegenerative disorders, heart disease, and diabetes. Studies have shown that PABPC1L1 is expressed in the brains of individuals with neurodegenerative disorders, and that it is involved in the regulation of neurodegeneration. In addition, PABPC1L1 has been shown to be involved in the regulation of insulin sensitivity and metabolism, which is important for the development and progression of type 2 diabetes.

Conclusion

PABPC1L1 is a protein that is involved in a number of important cellular processes that are linked to human disease. While its exact function is not yet well understood, research has shown that it is involved in the regulation of inflammation, cell signaling, stress resistance, and metabolism. As a potential drug target and biomarker, PABPC1L1 is a promising target for the development of new therapies for a number of diseases. Further research is needed to fully understand its role in these processes and its potential as a drug.

Protein Name: Poly(A) Binding Protein Cytoplasmic 1 Like

The "PABPC1L Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PABPC1L comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets